Nuclear Regulatory Commission
The U.S. Nuclear Regulatory Commission (NRC) is amending its regulations to address the financial criteria used to determine whether a utilization facility that is useful in the conduct of research and development activities is licensed as a commercial facility under section 103, "Commercial Licenses," of the Atomic Energy Act of 1954, as amended, or as a research and development facility under section 104, "Medical Therapy and Research and Development." This rulemaking revises the NRC's regulations to be consistent with the Nuclear Energy Innovation and Modernization Act, enacted on January 14, 2019, and the Accelerating Deployment of Versatile, Advanced Nuclear for Clean Energy Act of 2024, enacted on July 9, 2024.
Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Nuclear Regulatory Commission 10 CFR Part 50 [NRC-2020-0071] RIN 3150-AL35 ( printed page 21937) AGENCY: Nuclear Regulatory Commission. ACTION: Final rule. SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is amending its regulations to address the financial criteria used to determine whether a utilization facility that is useful in the conduct of research and development activities is licensed as a commercial facility under section 103, “Commercial Licenses,” of the Atomic Energy Act of 1954, as amended, or as a research and development facility under section 104, “Medical Therapy and Research and Development.” This rulemaking revises the NRC's regulations to be consistent with the Nuclear Energy Innovation and Modernization Act, enacted on January 14, 2019, and the Accelerating Deployment of Versatile, Advanced Nuclear for Clean Energy Act of 2024, enacted on July 9, 2024. DATES: This final rule is effective on April 24, 2026. ADDRESSES: Please refer to Docket ID NRC-2020-0071 when contacting the NRC about the availability of information for this action. You may obtain publicly available information related to this action by any of the following methods: Federal Rulemaking Website: Electronically at https://www.regulations.gov . Search for Docket ID NRC-2020-0071. Address questions about NRC dockets to Helen Chang; telephone: 301-415-3228; email: Helen.Chang@nrc.gov . For technical questions, contact the individuals listed in the FOR FURTHER INFO…
Citation: 91 FR 21937
